Search results

Filters

  • Journals
  • Authors
  • Keywords
  • Date
  • Type

Search results

Number of results: 2
items per page: 25 50 75
Sort by:
Download PDF Download RIS Download Bibtex

Abstract

Candida albicans, a polymorphic yeast, is a physiological component of the human and animal commensal microbiome. It is an etiological factor of candidiasis, which is treated by azole antifungals. Growing resistance to azoles is a reason to look for other alternative treatment options. The pharmacotherapeutic use of plant extracts and essential oils has become increasingly important. In our experiment, C. albicans showed susceptibility to four observed plant extracts and essential oils from peppermint ( Mentha piperita), thyme ( Thymus vulgaris), sage ( Salvia officinalis), and oregano ( Origanum vulgare). Oregano plant extract and essential oil showed the highest antifungal activity, at MIC values of 4.9 mg/mL and 0.4 mg/mL respectively. Therefore, it was subjected to further research on the influence of virulence factors – biofilm formation, extracellular phospholipase production and germ tube formation. Oregano plant extract and essential oil showed an inhibitory effect on the observed C. albicans virulence factors at relatively low concentrations. The extract inhibited the adherence of cells at MIC 12.5 mg/mL and essential oil at MIC 0.25 mg/mL. Degradation of the formed biofilm was detected at MIC 14.1 mg/mL for plant extract and at MIC 0.4 mg/mL for essential oil. Extracellular phospholipase production was most effectively inhibited by the essential oil. In particular, the number of isolates with intensive extracellular phospholipase production decreased significantly. Of the 12 isolates intensively producing extracellular phospholipase, only 1 isolate (4.5%) retained intense production. Essential oil caused up to a 100 % reduction in germ tubes formation and plant extract reduced their formation depending on the concentration as follows: 2.6% (0.8 mg/mL), 21.2 % (6.25 mg/mL), and 64.5 % (12.5 mg/mL) compared to the control.
Go to article

Bibliography

1. Brondani LP, da Silva Neto TA, Freitag RA, Lund RG (2018) Evaluation of anti-enzyme properties of Origanum vulgare essential oil against oral Candida albicans. J Mycol Med 28: 94-100.
2. CLSI, Clinical and Laboratory Standards Institute (2017) M27-A3: Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. 4th ed. USA: Wayne, PA.
3. de Souza Ramos L, Barbedo LS, Braga-Silva LA, dos Santos AL, Pinto MR, da Graça Sgarbi DB (2015) Protease and phospholipase activities of Candida spp. isolated from cutaneous candidiasis. Rev Iberoam Micol 32: 122-125.
4. Doke SK, Raut JS, Dhawale S, Karuppayil SM (2014) Sensitization of Candida albicans biofilms to fluconazole by terpenoids of plant origin. J Gen Appl Microbiol 60: 163-168.
5. Edelmann A, Krüger M, Schmid J (2005) Genetic relationship between human and animal isolates of Candida albicans. J Clin Micro-biol 43: 6164-6166.
6. Ellepola AN, Samaranayake LP, Khan ZU (2016) Extracellular phospholipase production of oral Candida albicans isolates from smok-ers, diabetics, asthmatics, denture wearers and healthy individuals following brief exposure to polyene, echinocandin and azole antimy-cotics. Braz J Microbiol 47: 911-916.
7. Fule SR, Das D, Fule RP (2015) Detection of phospholipase activity of Candida albicans and non albicans isolated from women of reproductive age with vulvovaginal candidiasis in rural area. Indian J Med Microbiol 33: 92-95.
8. Jin Y, Yip HK, Samaranayake YH, Yau JY, Samaranayake LP (2003) Biofilm-forming ability of Candida albicans is unlikely to con-tribute to high levels of oral yeast carriage in cases of human immunodeficiency virus infection. J Clin Microbiol 41: 2961-2967.
9. Kumamoto CA, Gresnigt MS, Hube B (2020) The gut, the bad and the harmless: Candida albicans as a commensal and opportunistic pathogen in the intestine. Curr Opin Microbiol 56: 7-15.
10. Lee H, Woo ER, Lee DG (2018) Apigenin induces cell shrinkage in Candida albicans by membrane perturbation. FEMS Yeast Res 18: 10.1093.
11. Martins N, Ferreira IC, Barros L, Silva S, Henriques M (2014) Candidiasis: predisposing factors, prevention, diagnosis and alternative treatment. Mycopathologia 177: 223-240.
12. Mattei AS, Alves SH, Severo CB, da Silva Guazzelli L, de Mattos Oliveira F, Severo LC (2013) Determination of germ tube, phos-pholipase, and proteinase production by bloodstream isolates of Candida albicans. Rev Soc Bras Med Trop 46: 340-342.
13. Mohandas V, Ballal M (2011) Distribution of Candida species in different clinical samples and their virulence: biofilm formation, pro-teinase and phospholipase production: a study on hospitalized patients in southern India. J Glob Infect Dis 3: 4-8.
14. Nagy M, Mučaji P, Grančai D (2017) Pharmacognosy. Biologically active plant metabolites and their sources, 2nd ed., Bratislava, Herba.
15. Pozzatti P, Loreto ES, Nunes Mario DA, Rossato L, Santurio JM, Alves SH (2010) Activities of essential oils in the inhibition of Can-dida albicans and Candida dubliniensis germ tube formation. J Mycol Med 20: 185-189.
16. Pristov KE, Ghannoum MA (2019) Resistance of Candida to azoles and echinocandins worldwide. Clin Microbiol Infect 25: 792-798.
17. Raut JS, Karuppayil SM (2014) A status review on the medicinal properties of essential oils. Ind Crop Prod 62: 250-264.
18. Rossoni RD, Barbosa JO, Vilela SF, dos Santos JD, Jorge AO, Junqueira JC (2013) Correlation of phospholipase and proteinase pro-duction of Candida with in vivo pathogenicity in Galleria mellonella. Braz J Oral Sci 12: 199-204.
19. Ruchi T, Sujata B, Anuradha D (2015) Comparison of phenotypic methods for the detection of biofilm production in uro-pathogens in a tertiary care hospital in India. Int J Curr Microbiol App Sci 4: 840-849.
20. Seyedmousavi S, Bosco SM, de Hoog S, Ebel F, Elad D, Gomes RR, Jacobsen ID, Jensen HE, Martel A, Mignon B, Pasmans F, Piecková E, Rodrigues AM, Singh K, Vicente VA, Wibbelt G, Wiederhold NP, Guillot J (2018) Fungal infections in animals: a patch-work of different situations. Med Mycol 56 (Suppl 1): 165-187.
21. Silva S, Rodrigues CF, Araújo D, Rodrigues ME, Henriques M (2017) Candida species biofilms’ antifungal resistance. J Fungi (Ba-sel) 3: 8.
22. Vitális E, Nagy F, Tóth Z, Forgács L, Bozó A, Kardos G, Majoros L, Kovács R (2020) Candida biofilm production is associated with higher mortality in patients with candidaemia. Mycoses 63: 352-360.
Go to article

Authors and Affiliations

P. Váczi
1
M. Proškovcová
1
E. Čonková
1
D. Marcinčáková
1
M. Bačkorová
2
M. Harčárová
3

  1. Department of Pharmacology and Toxicology
  2. Department of Pharmaceutical Technology, Pharmacognosy and Botany
  3. Department of Animal Nutrition and Husbandry, University of Veterinary Medicine and Pharmacy, Komenského 73, Košice, 041 81, Slovakia

This page uses 'cookies'. Learn more